Albuquerque Clinical Trials, Inc.

The trials here

What the 23 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes7 trials
• Migraine5 trials
• Obesity4 trials
• Osteoarthritis2 trials
• Rheumatoid arthritis2 trials
• Atopic dermatitis (eczema)1 trial
• Coeliac disease1 trial
• Cytomegalovirus infection1 trial
• Gout1 trial
• Graves' disease1 trial
• Irritable bowel syndrome1 trial
• Type 1 diabetes1 trial

Phase

• Phase 311 trials
• Phase 28 trials
• Phase 43 trials
• Phase 2/31 trial

Status

• Completed10 trials
• Recruiting4 trials
• Terminated4 trials
• Active, not recruiting2 trials
• Suspended2 trials
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company5 trials
• Pfizer4 trials
• Novo Nordisk A/S2 trials
• TriGemX Bio, Inc.2 trials
• AEON Biopharma, Inc.1 trial
• and 9 more

Running trials

• Recruiting

  A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

  NCT07919678· Phase 3· Pfizer· Source

• Recruiting

  Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  NCT07817251· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Recruiting

  A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  NCT07595549· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  NCT07340320· Phase 2· Corxel Pharmaceuticals· Source

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  NCT07321886· Phase 3· Eli Lilly and Company· Source

  Contact: Satkirin Khalsa (principal investigator)

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  NCT07282600· Phase 3· Eli Lilly and Company· Source

  Contact: Satkirin Khalsa (principal investigator)

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity4 recruiting
• Type 2 diabetes4 recruiting
• Osteoarthritis1 recruiting

Closed trials

• Completed

  Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

  NCT07145229· Phase 2· Atom Therapeutics Co., Ltd· Source

• Terminated

  A Study of K-645 in the Treatment of Multiple Migraine Attacks

  NCT07116499· Phase 2· TriGemX Bio, Inc.· Source

• Completed

  A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

  NCT07006792· Phase 4· Eli Lilly and Company· Source

• Completed

  A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

  NCT06848075· Phase 2· TriGemX Bio, Inc.· Source

• Completed

  A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

  NCT06192108· Phase 3· Eli Lilly and Company· Source

• Terminated

  Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

  NCT06153420· Phase 2· CinPhloro Pharma, LLC· Source

• Completed

  Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

  NCT05518123· Phase 4· Pfizer· Source

• Completed

  Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

  NCT05449132· Phase 3· Grünenthal GmbH· Source

• Completed

  Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

  NCT04530123· Phase 2· Takeda· Source

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· Phase 3· ModernaTX, Inc.· Source

• Terminated

  A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

  NCT04804033· Phase 2/3· Pfizer· Source

• Completed

  Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults

  NCT04845178· Phase 2· AEON Biopharma, Inc.· Source

• Completed

  A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

  NCT03915964· Phase 4· Eli Lilly and Company· Source

• Completed

  Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

  NCT03025308· Phase 3· Alfasigma S.p.A.· Source